Type 2 diabetes, cardiovascular risk, and the link to insulin resistance
Authors:
- Mark W. StolarMSMark W. Stolar
- Robert J. ChiltonRCRobert J. Chilton
- 1 January 2003
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 25, B4-B31
Abstract
No abstract availableKeywords
This publication has 166 references indexed in Scilit:
- Endothelial dysfunction in diabetesBritish Journal of Pharmacology, 2000
- Oxidation of Tetrahydrobiopterin by Peroxynitrite: Implications for Vascular Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Pulmonary Edema Associated With Troglitazone TherapyArchives of internal medicine (1960), 1999
- Thiazolidinediones Down-Regulate Plasminogen Activator Inhibitor Type 1 Expression in Human Vascular Endothelial Cells: A Possible Role for PPARγ in Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Thiazolidinediones Suppress Endothelin-1 Secretion from Bovine Vascular Endothelial Cells: A New Possible Role of PPARγ on Vascular Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Diabetic dyslipidemiaThe American Journal of Cardiology, 1998
- Serum Leptin Concentration and Insulin Sensitivity in Men with Abdominal ObesityObesity Research, 1998
- Relationship between obesity and the increased risk of major complications in non‐insulin‐dependent diabetes mellitusEuropean Journal of Clinical Investigation, 1998
- Atherosclerosis: Risk factors and the vascular endotheliumAmerican Heart Journal, 1996
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990